Search Results - "Carlo Lucioni"
-
1
Value of health technologies, HTA and decisions
Published in Global & regional health technology assessment (Online) (01-01-2017)“…Value of health technologies, HTA and decisionsHTA is a multifaceted discipline, and several themes are key to an in-depth analysis of its current and future…”
Get full text
Journal Article -
2
The cost of unresectable stage III or stage IV melanoma in Italy
Published in Journal of experimental & clinical cancer research (01-11-2012)“…In recent decades, melanoma incidence has been increasing in European countries; in 2006, there were approximately 60,000 cases leading to 13,000 deaths…”
Get full text
Journal Article -
3
Value of health technologies, HTA and decisions: Valore delle tecnologie sanitarie, HTA, decisioni
Published in Global & regional health technology assessment (Online) (11-11-2019)Get full text
Journal Article -
4
Il Significato di un titolo: Global e Regional Health Technology Assessment
Published in Global & regional health technology assessment (Online) (06-12-2014)Get full text
Journal Article -
5
Il Significato di un titolo: Global & Regional Health Technology Assessment
Published in Global & regional health technology assessment (Online) (01-01-2014)Get full text
Journal Article -
6
Valore delle tecnologie sanitarie, HTA, decisioni
Published in Global & regional health technology assessment (Online) (2017)“…Value of health technologies, HTA and decisions HTA is a multifaceted discipline, and several themes are key to an in-depth analysis of its current and future…”
Get full text
Journal Article -
7
Health care costs of comorbidities in patients with HIV infection in Italy. An estimate using a Delphi panel
Published in Farmeconomia: Health Economics and Therapeutic Pathways (15-03-2006)“…In HIV affected patients, co-morbidities (also termed opportunistic infections or AIDS-defining events) characterise the disease progression, resulting from…”
Get full text
Journal Article -
8
First drug utilization data related to an anticholinergic agent recently marketed in Italy
Published in Farmeconomia: Health Economics and Therapeutic Pathways (15-09-2006)“…A retrospective drug utilisation study was conducted, concerning a new bronchodilator (tiotropium, ATC code: R03BB04) in the first six months after its launch…”
Get full text
Journal Article -
9
Cost of an outbreak of hepatitis A in Puglia, Italy
Published in PharmacoEconomics (01-02-1998)“…In total, 5889 cases of hepatitis A virus infection were reported during an outbreak in Puglia, a region of Southern Italy, in 1996. The primary cause of the…”
Get full text
Journal Article -
10
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
Published in Human vaccines & immunotherapeutics (02-08-2016)“…The European Medicines Agency has approved a multicomponent serogroup B meningococcal vaccine (Bexsero®) for use in individuals of 2 months of age and older. A…”
Get full text
Journal Article -
11
Budget impact analysis of infliximab biosimilar: the Italian scenery
Published in Global & regional health technology assessment (Online) (01-05-2015)Get full text
Journal Article -
12
-
13
Social cost of chronic pain in Italy
Published in Global & regional health technology assessment (Online) (01-01-2015)Get full text
Journal Article -
14
Cost-Effectiveness Evaluation of Oncological Drugs Newly Marketed in Italy
Published in Global & regional health technology assessment (Online) (01-07-2014)Get full text
Journal Article -
15
Letter to the Editor
Published in Vaccine (10-03-2006)“…[...]the difference is not negligible and may have important implications for decision makers since, as the Authors remind, the "commonly accepted benchmarks…”
Get full text
Journal Article -
16
Cost-effectiveness of universal pneumococcal vaccination for infants in Italy
Published in Vaccine (10-03-2006)Get full text
Journal Article -
17
-
18
Economic Evaluation of Levosimendan Versus Dobutamine for the Treatment of Acute Heart Failure in Italy
Published in Advances in therapy (01-12-2012)“…Introduction Inodilators are the first-choice class of drugs for the treatment of acute heart failure (AHF). Levosimendan is a relatively recent inodilatory…”
Get full text
Journal Article -
19
Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy
Published in Global & regional health technology assessment (Online) (01-01-2015)Get full text
Journal Article -
20
Cost of Cystic Fibrosis: Analysis of Treatment Costs in a Specialized Center in Northern Italy
Published in Advances in therapy (01-02-2013)“…Introduction Advances in cystic fibrosis (CF) therapy have resulted in improved survival and increasing treatment burden and costs. The economic impact of…”
Get full text
Journal Article